Sex differences in vaccine-induced humoral immunity.


Journal

Seminars in immunopathology
ISSN: 1863-2300
Titre abrégé: Semin Immunopathol
Pays: Germany
ID NLM: 101308769

Informations de publication

Date de publication:
03 2019
Historique:
received: 07 10 2018
accepted: 15 10 2018
pubmed: 14 12 2018
medline: 3 4 2020
entrez: 15 12 2018
Statut: ppublish

Résumé

Vaccines are among the most impactful public health interventions, preventing millions of new infections and deaths annually worldwide. However, emerging data suggest that vaccines may not protect all populations equally. Specifically, studies analyzing variation in vaccine-induced immunity have pointed to the critical impact of genetics, the environment, nutrition, the microbiome, and sex in influencing vaccine responsiveness. The significant contribution of sex to modulating vaccine-induced immunity has gained attention over the last years. Specifically, females typically develop higher antibody responses and experience more adverse events following vaccination than males. This enhanced immune reactogenicity among females is thought to render females more resistant to infectious diseases, but conversely also contribute to higher incidence of autoimmunity among women. Dissection of mechanisms which underlie sex differences in vaccine-induced immunity has implicated hormonal, genetic, and microbiota differences across males and females. This review will highlight the importance of sex-dependent differences in vaccine-induced immunity and specifically will address the role of sex as a modulator of humoral immunity, key to long-term pathogen-specific protection.

Identifiants

pubmed: 30547182
doi: 10.1007/s00281-018-0726-5
pii: 10.1007/s00281-018-0726-5
pmc: PMC6373179
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

239-249

Références

Mol Cell Proteomics. 2014 Nov;13(11):3029-39
pubmed: 25004930
Sci Rep. 2016 Jun 15;6:27955
pubmed: 27302155
Immunol Rev. 1994 Apr;138:39-59
pubmed: 7915248
Gynecol Oncol. 2001 May;81(2):254-62
pubmed: 11330959
Immunol Lett. 2011 Jun 30;137(1-2):28-37
pubmed: 21300106
Clin Diagn Lab Immunol. 2000 Jan;7(1):111-3
pubmed: 10618288
Clin Genet. 1979 Mar;15(3):221-7
pubmed: 570466
Vaccine. 2013 May 28;31(23):2599-600
pubmed: 23579257
Inflammation. 1996 Oct;20(5):485-98
pubmed: 8894713
Blood. 2012 Jan 12;119(2):454-64
pubmed: 22096248
Semin Immunopathol. 2017 Nov;39(6):605-613
pubmed: 28971246
Sci Rep. 2017 Mar 17;7:44727
pubmed: 28303960
PLoS Pathog. 2010 Nov 18;6(11):e1001190
pubmed: 21124987
Pediatr Infect Dis J. 2010 Apr;29(4):324-8
pubmed: 19934785
JCI Insight. 2017 Feb 23;2(4):e89703
pubmed: 28239652
Nature. 1993 Feb 11;361(6412):539-41
pubmed: 7679206
Shock. 2000 Sep;14(3):354-9; discussion 359-60
pubmed: 11028556
Lancet Infect Dis. 2010 May;10(5):338-49
pubmed: 20417416
Vaccine. 2017 May 2;35(19):2600-2604
pubmed: 28365252
PLoS One. 2016 Apr 27;11(4):e0153003
pubmed: 27119988
J Mark Access Health Policy. 2015 Aug 12;3:
pubmed: 27123189
J Virol. 2012 Dec;86(24):13467-74
pubmed: 23035224
Med Dosw Mikrobiol. 2013;65(4):269-74
pubmed: 24730215
Expert Rev Vaccines. 2018 Sep;17(9):785-795
pubmed: 30145912
Am J Trop Med Hyg. 2002 May;66(5):533-41
pubmed: 12201587
Expert Opin Biol Ther. 2008 Nov;8(11):1659-67
pubmed: 18847302
Trans R Soc Trop Med Hyg. 2015 Jan;109(1):9-15
pubmed: 25573105
Arch Intern Med. 2008 Dec 8;168(22):2405-14
pubmed: 19064822
Nat Immunol. 2009 Jan;10(1):116-125
pubmed: 19029902
Nat Med. 2009 Aug;15(8):955-9
pubmed: 19597505
Front Immunol. 2014 Oct 20;5:520
pubmed: 25368619
MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34
pubmed: 23760231
Immunity. 2015 Mar 17;42(3):580-90
pubmed: 25786180
Vaccine. 2014 Sep 29;32(43):5638-44
pubmed: 25148772
Vaccine. 2015 Oct 13;33(42):5546-5552
pubmed: 26382601
Vaccine. 2002 May 31;20 Suppl 3:S48-50
pubmed: 12184365
Shock. 2001 Nov;16(5):340-3
pubmed: 11699070
Hum Vaccin Immunother. 2015;11(9):2132-41
pubmed: 26075806
Hum Vaccin Immunother. 2017 Jun 3;13(6):1-9
pubmed: 28332900
Clin Vaccine Immunol. 2014 Aug;21(8):1023-36
pubmed: 24920599
N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
Transl Res. 2011 Apr;157(4):163-79
pubmed: 21420027
Science. 2013 Mar 1;339(6123):1084-8
pubmed: 23328391
Mol Immunol. 2016 Aug;76:13-21
pubmed: 27337595
Trends Immunol. 2017 May;38(5):358-372
pubmed: 28385520
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Annu Rev Cell Dev Biol. 2017 Oct 6;33:577-599
pubmed: 28992436
Cancer Res. 2017 Apr 15;77(8):1783-1812
pubmed: 28292977
Vaccine. 2016 Mar 29;34(14):1657-64
pubmed: 26920472
Bone. 2001 Jul;29(1):30-4
pubmed: 11472888
Biomed Res Int. 2013;2013:928290
pubmed: 23509808
Vaccine. 2000 Oct 15;19(4-5):523-9
pubmed: 11027817
Trends Immunol. 2014 Mar;35(3):97-104
pubmed: 24239225
Vaccine. 2008 Jul 4;26(29-30):3551-5
pubmed: 18524433
Genes Immun. 2009 Jul;10(5):509-16
pubmed: 19279650
Arthritis Rheum. 2004 Jun;50(6):1967-75
pubmed: 15188374
Hum Vaccin. 2009 Jul;5(7):441-9
pubmed: 19377279
BMJ. 1992 Apr 25;304(6834):1075-8
pubmed: 1586818
J Immunol. 2006 Aug 15;177(4):2088-96
pubmed: 16887967
Handb Exp Pharmacol. 2012;(214):411-42
pubmed: 23027461
J Immunol. 1996 Sep 1;157(5):2168-73
pubmed: 8757343
J Virol. 2018 Sep 12;92(19):
pubmed: 30021899
Vaccine. 2017 Dec 15;35(50):7018-7025
pubmed: 29107347
Semin Hematol. 2010 Apr;47(2):115-23
pubmed: 20350658
J Exp Med. 2004 Jun 21;199(12):1659-69
pubmed: 15210744
Vaccine. 2003 Jul 28;21(24):3365-9
pubmed: 12850341
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S33-40
pubmed: 20061006
Infect Immun. 1978 Aug;21(2):532-9
pubmed: 357289
Nat Rev Immunol. 2010 Aug;10(8):594-604
pubmed: 20651746
Trends Parasitol. 2016 Nov;32(11):887-898
pubmed: 27546781
Cell. 2016 Oct 6;167(2):433-443.e14
pubmed: 27667685
J Immunol. 2009 Feb 15;182(4):1789-93
pubmed: 19201829
J Infect Dis. 2014 Jul 15;209 Suppl 3:S86-92
pubmed: 24966195
Mol Endocrinol. 2003 Dec;17(12):2509-18
pubmed: 12933903
Front Immunol. 2018 Mar 21;9:552
pubmed: 29619026
Clin Vaccine Immunol. 2010 Jul;17(7):1055-65
pubmed: 20463105
Age Ageing. 2011 Sep;40(5):568-75
pubmed: 21807702
J Immunol. 2015 Mar 15;194(6):2769-75
pubmed: 25667414
PLoS One. 2012;7(8):e42867
pubmed: 22880124
Clin Sci (Lond). 2016 Aug 1;130(16):1435-51
pubmed: 27389589
Exp Gerontol. 2013 May;48(5):472-5
pubmed: 23422355
Horm Behav. 2012 Aug;62(3):263-71
pubmed: 22406114
Vaccine. 2008 Nov 11;26(48):6077-82
pubmed: 18809449
Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S17-20
pubmed: 22920053
Ann Ist Super Sanita. 2016 Apr-Jun;52(2):198-204
pubmed: 27364394
Nat Rev Immunol. 2009 May;9(5):313-23
pubmed: 19343057
Vaccine. 2011 Jan 10;29(3):487-500
pubmed: 21093496
Adv Physiol Educ. 2013 Dec;37(4):284-91
pubmed: 24292903
Obstet Gynecol Clin North Am. 2014 Dec;41(4):521-34
pubmed: 25454988
Autoimmun Rev. 2012 May;11(6-7):A479-85
pubmed: 22155201
J Proteome Res. 2014 Mar 7;13(3):1657-68
pubmed: 24527664
J Infect Dis. 2004 Dec 1;190(11):1970-8
pubmed: 15529262
FEMS Immunol Med Microbiol. 2000 Sep;29(1):47-52
pubmed: 10967260
Vaccine. 2002 Jun 7;20(19-20):2494-9
pubmed: 12057604
Expert Opin Drug Saf. 2009 Mar;8(2):211-21
pubmed: 19309249
J Immunol. 2005 May 15;174(10):6023-9
pubmed: 15879095
J Reprod Immunol. 2001 May;50(2):151-9
pubmed: 11334996
Expert Rev Vaccines. 2013 May;12(5):519-36
pubmed: 23659300
Blood. 2012 Apr 5;119(14):3276-84
pubmed: 22337718
Immunity. 2014 Sep 18;41(3):349-351
pubmed: 25238091

Auteurs

Stephanie Fischinger (S)

Ragon Institute of MGH, MIT, and Harvard, 400 Technology Square, Cambridge, MA, 02139, USA.
Institut für HIV Forschung, Universität Duisburg-Essen, Duisburg, Germany.

Carolyn M Boudreau (CM)

Ragon Institute of MGH, MIT, and Harvard, 400 Technology Square, Cambridge, MA, 02139, USA.

Audrey L Butler (AL)

Ragon Institute of MGH, MIT, and Harvard, 400 Technology Square, Cambridge, MA, 02139, USA.

Hendrik Streeck (H)

Institut für HIV Forschung, Universität Duisburg-Essen, Duisburg, Germany.

Galit Alter (G)

Ragon Institute of MGH, MIT, and Harvard, 400 Technology Square, Cambridge, MA, 02139, USA. galter@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH